Data as of Nov 21
| +0.22 / +3.91%|
Cancer Genetics, Inc. is a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's proprietary tests target cancers where prognosis information is critical and where predicting treatment outcomes using currently available techniques is limited. These cancers include hematological, urogenital and HPV-associated cancers. It provides tests and services to oncologists and pathologists at hospitals, cancer centers, and physician offices. Cancer Genetics was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.
|Panna L. Sharma||President, Chief Executive Officer & Director|
|Edward J. Sitar||Chief Financial Officer & Treasurer|
|Lan Wang||Medical Director|
|Jane Houldsworth El Naggar||Vice President-Research & Development|
|Weiyi Chen||Director-Molecular Diagnostics|